share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯维公司 | 144:拟议出售证券
美股SEC公告 ·  03/20 19:33

Moomoo AI 已提取核心信息

AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
艾伯维公司高管尼古拉斯·多诺霍定于2024年3月20日出售该公司的21,082股普通股,总市值约为372万美元。作为薪酬的一部分,这些股票于2024年2月28日作为绩效股直接从发行人手中收购。在2024年3月20日发布本通知之前的过去三个月中,没有可申报的Donoghoe出售证券的历史记录。
艾伯维公司高管尼古拉斯·多诺霍定于2024年3月20日出售该公司的21,082股普通股,总市值约为372万美元。作为薪酬的一部分,这些股票于2024年2月28日作为绩效股直接从发行人手中收购。在2024年3月20日发布本通知之前的过去三个月中,没有可申报的Donoghoe出售证券的历史记录。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息